ArticleBMC psychiatry2026
Psychiatric comorbidity of depression and anxiety in medical trainees: prevalence and predictors in Ecuador.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDepression and anxiety are highly prevalent among medical trainees, yet their comorbidity remains underexplored. Comorbid symptoms are linked to greater severity, functional impairment, and poorer outcomes than either disorder alone. This study examined the prevalence and predictors of depression–anxiety comorbidity among medical trainees in Ecuador.
methodsWe conducted a cross-sectional survey of 700 students (393 undergraduates, 307 postgraduates) at a private university in Quito from January to March 2025. Depressive symptoms were assessed with the PHQ-9, anxiety with the GAD-7, and alcohol use with the AUDIT. Comorbidity was defined as PHQ-9 ≥10 and GAD-7 ≥10. Logistic regression identified sociodemographic, academic, and clinical predictors.
resultsClinically significant depression was reported by 47.71%, anxiety by 44.57%, and comorbidity by 36.71%. Prevalence was higher among undergraduates than postgraduates for depression (54.71% vs. 38.76%), anxiety (52.92% vs. 33.87%), and comorbidity (43.26% vs. 28.34%) (all p < 0.001). In multivariable analysis, higher odds of comorbidity were independently associated with female gender (AOR = 1.66, 95% CI: 1.15–2.40), chronic illness (AOR = 1.89, 95% CI: 1.30–2.77), and undergraduate status (AOR = 2.67, 95% CI: 1.55–4.65). Tobacco use and night shifts showed positive but nonsignificant associations.
conclusionMore than one-third of medical trainees reported depression–anxiety comorbidity, highlighting a distinct and underrecognized challenge in Latin America. Findings emphasize the need for early, stage-sensitive, and gender-responsive interventions, as well as accommodations for students with chronic illness. Addressing comorbidity is critical to improving trainee well-being and sustaining medical education quality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.